ROCKWELL MEDICAL, INC. Deferred Tax Assets, Operating Loss Carryforwards
ROCKWELL MEDICAL, INC. (RMTI) had Deferred Tax Assets, Operating Loss Carryforwards of $72.89 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $72.89M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $71.42M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $72.61M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $70.69M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $72.89M 10-K · filed 2026-03-26 |
| 2024-12-31 | $71.42M 10-K · filed 2026-03-26 |
| 2023-12-31 | $72.61M 10-K · filed 2025-03-20 |
| 2022-12-31 | $70.69M 10-K · filed 2024-03-21 |
| 2021-12-31 | $66.89M 10-K · filed 2023-03-30 |
| 2020-12-31 | $59.59M 10-K · filed 2022-04-08 |
| 2019-12-31 | $52.94M 10-K · filed 2021-03-31 |
| 2018-12-31 | $45.05M 10-K · filed 2020-03-17 |
| 2017-12-31 | $35.03M 10-K · filed 2019-03-18 |
| 2016-12-31 | $51.46M 10-K · filed 2018-03-15 |
| 2015-12-31 | $52.67M 10-K · filed 2017-03-15 |
| 2014-12-31 | $49.46M 10-K · filed 2016-02-29 |
| 2013-12-31 | $49.43M 10-K · filed 2015-03-03 |
| 2012-12-31 | $33.02M 10-K · filed 2014-03-07 |
| 2011-12-31 | $16.73M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |